Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €21.35B | €21.88B | €27.25B | €24.57B | €15.62B | €14.44B |
| Gross profit | €3.16B | €3.17B | €3.66B | €3.13B | €1.88B | €1.47B |
| Gross margin | 14.81% | 14.48% | 13.44% | 12.74% | 12.06% | 10.20% |
| Research & development | €832.0M | €852.4M | €953.0M | €896.0M | €330.9M | €341.7M |
| Operating expenses | €2.06B | €2.18B | €2.42B | €2.26B | — | — |
| Operating income | €1.10B | €986.0M | €1.25B | €870.6M | — | — |
| Operating margin | 5.17% | 4.51% | 4.57% | 3.54% | — | — |
| EBITDA | €897.8M | €1.78B | €2.55B | €1.83B | — | — |
| EBITDA margin | 4.21% | 8.14% | 9.38% | 7.46% | — | — |
| Net income | −€2.09B | −€185.2M | €365.6M | −€250.4M | €16.2M | −€321.5M |
| Net profit margin | −9.80% | −0.85% | 1.34% | −1.02% | 0.10% | −2.23% |
| Basic EPSper basic share | €0.88 | -€0.94 | €1.13 | -€2.20 | -€0.57 | -€2.75 |
| Diluted EPSper diluted share | €0.88 | -€0.94 | €1.12 | -€2.20 | -€0.57 | -€2.75 |